TY - JOUR
T1 - Effects of a workplace exercise intervention on cardiometabolic health
T2 - Study protocol for a randomised controlled trial
AU - Alrahma, Ali Muneer
AU - Habib, Mansoor Anwar
AU - Oulhaj, Abderrahim
AU - Loney, Tom
AU - Boillat, Thomas
AU - Shah, Syed M.
AU - Ahmed, Luai A.
AU - Nauman, Javaid
N1 - Publisher Copyright:
© 2021 Author(s). Published by BMJ.
PY - 2021/11/3
Y1 - 2021/11/3
N2 - Introduction The worldwide rising levels of physical inactivity especially in the United Arab Emirates (ARE) and the Eastern Mediterranean region are alarming. The ARE reports one of the highest rates of non-communicable disease mortality and insufficient physical activity (PA) is a major underlying cause. Therefore, action is required to reduce physical inactivity using evidence-based strategies. This study aimed to evaluate the efficacy of a worksite exercise intervention on cardiometabolic health in the ARE. Methods and analysis This is a protocol for a pragmatic parallel randomised controlled trial with a 1:1 allocation ratio to the intervention group and delayed intervention group. A total of 150 participants will be recruited from a semigovernment telecommunications company in Dubai (ARE) after meeting the eligibility criteria. The intervention group will receive 2 hours of exercise per week during working hours for 12 weeks (maximum 1 hour/day). The intervention group will be assigned to attend personal trainer sessions in the workplace gym throughout the intervention period. After the intervention is completed, the delayed intervention group will also receive 2 hours of exercise time per week from working hours for 4 weeks. The main outcome measure is the change in the cardiometabolic risk components, that is, systolic or diastolic blood pressure, waist circumference, glycated haemoglobin, fasting plasma glucose, low-density lipoprotein cholesterol from baseline to the end of the intervention. The secondary outcome is to examine whether the workplace exercise intervention improves PA levels 4 weeks postintervention. Ethics and dissemination The study has been approved by the Dubai Scientific Research Ethics Committee (DSREC-SR-08/2019_02). The results will be disseminated as follows: At various national and international scientific conferences; as part of a PhD thesis in Public Health at the College of Medicine and Health Sciences, ARE University; and in a manuscript submitted to a peer-reviewed journal.
AB - Introduction The worldwide rising levels of physical inactivity especially in the United Arab Emirates (ARE) and the Eastern Mediterranean region are alarming. The ARE reports one of the highest rates of non-communicable disease mortality and insufficient physical activity (PA) is a major underlying cause. Therefore, action is required to reduce physical inactivity using evidence-based strategies. This study aimed to evaluate the efficacy of a worksite exercise intervention on cardiometabolic health in the ARE. Methods and analysis This is a protocol for a pragmatic parallel randomised controlled trial with a 1:1 allocation ratio to the intervention group and delayed intervention group. A total of 150 participants will be recruited from a semigovernment telecommunications company in Dubai (ARE) after meeting the eligibility criteria. The intervention group will receive 2 hours of exercise per week during working hours for 12 weeks (maximum 1 hour/day). The intervention group will be assigned to attend personal trainer sessions in the workplace gym throughout the intervention period. After the intervention is completed, the delayed intervention group will also receive 2 hours of exercise time per week from working hours for 4 weeks. The main outcome measure is the change in the cardiometabolic risk components, that is, systolic or diastolic blood pressure, waist circumference, glycated haemoglobin, fasting plasma glucose, low-density lipoprotein cholesterol from baseline to the end of the intervention. The secondary outcome is to examine whether the workplace exercise intervention improves PA levels 4 weeks postintervention. Ethics and dissemination The study has been approved by the Dubai Scientific Research Ethics Committee (DSREC-SR-08/2019_02). The results will be disseminated as follows: At various national and international scientific conferences; as part of a PhD thesis in Public Health at the College of Medicine and Health Sciences, ARE University; and in a manuscript submitted to a peer-reviewed journal.
KW - diabetes & endocrinology
KW - hypertension
KW - occupational & industrial medicine
KW - preventive medicine
KW - public health
UR - http://www.scopus.com/inward/record.url?scp=85118921898&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85118921898&partnerID=8YFLogxK
U2 - 10.1136/bmjopen-2021-051070
DO - 10.1136/bmjopen-2021-051070
M3 - Article
C2 - 34732483
AN - SCOPUS:85118921898
SN - 2044-6055
VL - 11
JO - BMJ Open
JF - BMJ Open
IS - 11
M1 - e051070
ER -